Travelers Cos. Inc. closed 1.89% below its 52-week high of $269.56, which the company achieved on October 18th.
Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback